Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRansmural hEaliNg Definition in CroHn's Disease - The TRENCH1 Study

NCT05903066 is registered in ClinicalTrials.gov with Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives as lead sponsor.

NCT NCT05903066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05903066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRansmural hEaliNg Definition in CroHn's Disease - The TRENCH1 Study
Lead sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Phase
Observational
Overall status
Recruiting
Start date
September 28, 2023
Completion date
August 31, 2025
Enrollment
210 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease